Indberettede bivirkninger fra 185 patienter, der blev behandlet for superficielt basalcellekarcinom med Imiquimod- creme i placebokontrollerede kliniske forsøg i fase III, vises i nedenstående.
Patient reported adverse reactions from 185 patients treated with imiquimod cream in placebo controlled phase III clinical studies for superficial basal cell carcinoma are presented below.